Clinical snapshot — for veterinary teams
- Active ingredient / class: capromorelin — ghrelin-receptor agonist (mimics the “hunger hormone”); the first FDA-approved appetite stimulant of its kind; Entyce for dogs (Elura is the feline CKD version)
- Form/onset: flavored oral liquid (shake gently, dose with the syringe, rinse after each dose); takes effect in 1–2 hours
- Counsel clients on: diarrhea, vomiting, hypersalivation/drooling, increased thirst/urination, gas, nausea; usually well tolerated
- Bloodwork/caution: can elevate BUN (and phosphorus); use with caution in hepatic dysfunction or renal insufficiency; not for hypersensitivity or breeding/pregnant dogs
- The caveat: it stimulates appetite but doesn’t treat the underlying cause of inappetence (which is usually a sign of illness) — reassessment matters
- Don’t double a missed dose
Plain answer for owners who landed here: Entyce is a flavored liquid that makes dogs feel hungry — it works by mimicking the body’s natural “hunger hormone,” usually within an hour or two. Shake it gently, measure it with the provided syringe, and rinse the syringe after each dose. It’s generally well tolerated; the things to watch are drooling, stomach upset, and increased thirst. Importantly, a dog that stops eating is often telling you something is wrong — Entyce helps the appetite but doesn’t fix the cause, so keep working with your vet on the underlying problem and call if your dog still won’t eat.
What it’s used for — and why follow-up matters
Entyce is the first purpose-built appetite stimulant for dogs, and its follow-up profile centers on two things. First, it’s used in inappetent dogs, and inappetence is usually a symptom of illness (kidney disease, GI disease, cancer, medication effects) — so the key question is whether the dog is actually eating and whether the underlying cause is being addressed, not just whether appetite improved. Second, it has a manageable but real side-effect and bloodwork profile (GI effects, hypersalivation, elevated BUN), with cautions in liver/kidney compromise — exactly the patients who often need it. A short follow-up confirms it’s working, catches side effects, and keeps the focus on the real problem.
The adverse-event and monitoring profile
Per the FDA-approved labeling and veterinary references, Entyce is generally well tolerated; the most common effects are diarrhea, vomiting, hypersalivation, increased thirst/urination, gas, nausea, abdominal discomfort, and lethargy. Bloodwork can show elevated BUN (a kidney indicator) and phosphorus, and it should be used with caution in dogs with hepatic dysfunction or renal insufficiency — and avoided with capromorelin hypersensitivity or in breeding/pregnant dogs. It acts on the hypothalamic hunger centers (and increases growth-hormone secretion), with effect in 1–2 hours; the missed-dose rule is not to double up. (Sources: Entyce & Elura via PetMD; Capromorelin — VCA Animal Hospitals; Entyce capromorelin oral solution — Elanco.)
The follow-up window that matters
The window is the active inappetence episode — confirming the dog is eating within the first day or two, screening for GI/hypersalivation effects, and keeping the underlying condition in view. For dogs on it longer-term, ongoing reassessment of both response and the primary disease applies.
What to ask clients at follow-up
A response-and-cause check:
- Is your dog actually eating more — and within an hour or two of dosing?
- Any drooling, diarrhea, vomiting, or increased thirst?
- Are you dosing with the syringe correctly (and not doubling missed doses)?
- Is the underlying reason your dog stopped eating still being worked up/managed?
The “is the dog eating, and why did it stop?” framing is the one that matters most — appetite is a symptom, not the disease.
Where compliance breaks down
The defining issues are treating appetite while the underlying illness goes unaddressed, stopping too soon (or not recognizing non-response), and unreported GI/hypersalivation effects. All are follow-up gaps a quick check resolves.
Standardizing this follow-up without adding staff time
This is what Nidana Loop automates. After an Entyce prescription, Loop calls or texts to confirm the dog is eating, screen for GI effects and hypersalivation, reinforce correct syringe dosing, and keep the underlying condition in view (flagging persistent inappetence for reassessment) — returning it as a structured note and surfacing non-response or concerns to a vet. An appetite stimulant in a sick patient gets outcome surveillance, with no staff calls.
See Loop handle medication follow-up
Loop runs your appetite-response check and side-effect screen automatically — returning structured outcomes to the clinic. Book a 20-minute demo → · See how Loop works →
For pet owners
How does Entyce work? It mimics the body’s natural “hunger hormone” to make your dog feel hungry, usually within 1–2 hours.
How do I give it? Shake gently, measure with the provided syringe, and rinse the syringe after each dose.
What side effects should I watch for? Drooling, diarrhea or vomiting, and increased thirst are most common.
My dog still won’t eat — now what? Call your vet — inappetence is usually a sign of an underlying problem that Entyce doesn’t fix on its own.
This article is general information, not veterinary advice. Owners should consult their veterinarian and follow the product’s FDA-approved label.
Sources: Entyce & Elura via PetMD; Capromorelin — VCA Animal Hospitals; Entyce (capromorelin oral solution) — Elanco.